Bipolar Disorder Treatment Medications Treating Psychosis With Typical Antipsychotics Early Generation Drugs Still Used in First-Line Therapy By Marcia Purse Marcia Purse Marcia Purse is a mental health writer and bipolar disorder advocate who brings strong research skills and personal experiences to her writing. Learn about our editorial process Updated on October 24, 2020 Medically reviewed Verywell Mind articles are reviewed by board-certified physicians and mental healthcare professionals. Medical Reviewers confirm the content is thorough and accurate, reflecting the latest evidence-based research. Content is reviewed before publication and upon substantial updates. Learn more. by Daniel B. Block, MD Medically reviewed by Daniel B. Block, MD LinkedIn Twitter Daniel B. Block, MD, is an award-winning, board-certified psychiatrist who operates a private practice in Pennsylvania. Learn about our Medical Review Board Print Purestock / Getty Images Typical antipsychotics sometimes referred to as first-generation antipsychotics, are a class of psychotropic drug used to treat the symptoms of psychosis. Psychosis is defined as a behavior in which a person loses touch with reality, often manifesting with hallucinations and delusions. Typical antipsychotics have largely been supplanted in recent years by a newer class of drug known as atypical antipsychotics. Atypical antipsychotics were first introduced in the 1990s and generally have fewer side effects than their predecessors. However, evidence suggests that atypical antipsychotics are not as unencumbered by side effects as once believed. In fact, they are more likely to cause type 2 diabetes and weight gain. By contrast, typical antipsychotics are more likely to cause Parkinson disease-like rigidity and spasticity (sometimes permanent), and tardive dyskinesia (a neurological disorder characterized by involuntary, repetitive body movements). Despite the possible side effects, typical antipsychotics still have their place in the first-line treatment of certain mental illnesses as well as in subsequent therapies when other drugs fail. Conditions Associated With Psychotic Episodes Psychosis can be caused by psychiatric or physical illnesses that affect the brain and behavior. The mental illnesses most commonly associated with a psychotic episode include: Bipolar disorder Schizophrenia Post-traumatic stress disorder (PTSD) Psychotic depression Postpartum psychosis The physical conditions most commonly associated with psychosis include epilepsy, advanced HIV infection, Parkinson’s disease, stroke, brain tumors, aging-related dementia, and methamphetamine abuse. Approved Typical Antipsychotics Typical antipsychotics were first developed in the 1950s to treat psychosis. The usage of the drugs has since been expanded to include acute mania, agitation, and other serious mood disorders. Depending on your symptoms, the doctor may choose to use a low-potency, medium-potency, or high-potency typical antipsychotic. Generally speaking, the lower potency ones have more intolerable side effects but are slightly less likely to cause movement disorders. This is not always the case, of course, and the choice of drug depends as much on its appropriate use as its potency. In the end, typical antipsychotics are not one-size-fits-all. As such, treatment should always be individualized, although it may take several attempts before you hit upon the right drug combination. Low-potency typical antipsychotics include: Thorazine (chlorpromazine) Truxal (chlorprothixene) – not available in the U.S. Medium-potency typical antipsychotics include: Loxitane (loxapine) Navane (thiothixene) Trilafon (perphenazine) High-potency typical antipsychotics include: Clopixal (zuclopenthixol) – not available in the U.S.Compro (prochlorperazine)Depixol (flupentixol)Haldol (haloperidol)Majeptil (thioproperazine) – not available in the U.S.Mellaril (thioridazine)Prolixin (fluphenazine)Stelazine (trifluoperazine) Side Effects of Antipsychotics Side effects can vary based on the drug or combinations of drug used. Some of the side effects may be mild and short-lasting; others can compound over time and increase the risk of other undesirable effects. The biggest concern is the risk of extrapyramidal side effects (EPS), the tell-tale side effects that affect body movement and speech. In the past, the term "Thorazine shuffle" was coined because of the impact the drug had on movement and muscle control. The range of EPS can vary and may include: Acute dyskinesias (movement disorders characterized by involuntary muscle movements, tics, and diminished voluntary muscle control)Akasthisia (a feeling of inner restlessness and inability to stay still, often referred to as the "rabbit syndrome")Akinesia (loss or impairment of voluntary movement)Dystonic reactions (intermittent and involuntary contractions of the muscles of the face, neck, trunk, pelvis, and extremities)Parkinsonism (a group of neurological disorders that cause movement problems similar to Parkinson's disease, including tremors, slow movement, and stiffness)Tardive dyskinesia (often involving involuntary and repetitive facial movements, including sticking out one's tongue, grimacing, or making chewing motions) Other, less debilitating side effects include upset stomach, weight gain, dry mouth, blurry vision, constipation, vomiting, drowsiness, and orthostatic hypotension (low blood pressure when standing up). In rare cases, a life-threatening drug reaction, known as neuroleptic malignant syndrome, may occur, causing high fever, muscle rigidity, altered mental state, and dysfunction of the autonomic nervous system (which regulates heart rate, breathing rate, body temperature, digestion, and body sensations). Overall, EPS will affect three in five typical antipsychotic users to some degree. By contrast, atypical antipsychotics will cause EPS in one in four users. Similarly, high-potency typical antipsychotics are more likely to cause EPS, orthostatic hypotension, and drowsiness than low-potency one. While low-potency typical antipsychotics generally have fewer EPS symptoms, they are more likely to affect the parasympathetic nervous system, causing abnormally slowed heart rate, low blood pressure, blurry vision, dry mouth, and breathing constriction. In 2005, the U.S. Food and Drug Administration (FDA) issued a black box warning on all atypical antipsychotic drugs due to the increased risk of death in older adults with dementia-related psychosis. They extended this warning to typical antipsychotic medications in 2008. Combination Therapy When used to treat mental illness, antipsychotics are usually prescribed in combination with other drugs, such as mood stabilizers, antidepressants, and anti-anxiety medications. Mood stabilizers are used to help alleviate manic or hypomanic episodes. Options include Tegretol (carbamazepine), Depakene (valproic acid), Lithobid (lithium), and Depakote (divalproex sodium). Antidepressants are used to treat depression and may include any one of six classes of drug: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), norepinephrine and dopamine reuptake inhibitors (NDRIs), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), and atypical antidepressants. Anti-anxiety medications, also known as benzodiazepines, can help with sleep and anxiety problems but are generally prescribed for a short period of time. Options include Klonopin (clonazepam), Valium (diazepam), Ativan (lorazepam), and Xanax (alprazolam). 1 Source Verywell Mind uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Gill SS, Bronskill SE, Normand S-LT, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775-786. doi:10.7326/0003-4819-146-11-200706050-00006 Additional Reading Divac N, Prostran M, Jakovcevski I, Cerovac N. Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int. 2014;2014:656370. doi:10.1155/2014/656370 Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM, Correll CU. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(6):1205-18. doi:10.1017/S1461145712001277 Cunningham Owens, D. (2014) A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs (Second Edition). Cambridge (GB): Cambridge University Press. ISBN-10: 110702286X. Kasper, D.; Fauci, A.; Hauser, S. et al. (2011) Harrison's Principles of Internal Medicine (18th Edition). New York: McGraw Hill Education, 2015. ISBN-10: 007174889X. By Marcia Purse Marcia Purse is a mental health writer and bipolar disorder advocate who brings strong research skills and personal experiences to her writing. See Our Editorial Process Meet Our Review Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit Speak to a Therapist Online Advertiser Disclosure × The offers that appear in this table are from partnerships from which Verywell Mind receives compensation.